Overview Empagliflozin and Sympathetic Nerve Traffic Status: Completed Trial end date: 2020-04-20 Target enrollment: Participant gender: Summary In this study the effects of the Inhibition of the Sodium-Glucose Linked Transporter 2 in the kidney with empagliflozin compared to hydrochlorothiazide on blood pressure and on central sympathic nervous activity will be examined. Phase: Phase 4 Details Lead Sponsor: Profil Institut für Stoffwechselforschung GmbHTreatments: EmpagliflozinHydrochlorothiazide